We evaluate access and reimbursement issues to inform drug development and commercialization.
Examples include:
- Payer research and advisory boards
- Epidemiology and treatment algorithm analysis
- Value proposition and materials
- TPP evaluation
- Innovative contracting
Case Study Examples